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Abstract
Introduction—Psychiatric co-morbidity is common in Crohn’s disease (CD) and ulcerative
colitis (UC). IBD-related surgery or hospitalizations represent major events in the natural history
of disease. Whether there is a difference in risk of psychiatric co-morbidity following surgery in
CD and UC has not been examined previously.
Methods—We used a multi-institution cohort of IBD patients without a diagnosis code for
anxiety or depression preceding their IBD-related surgery or hospitalization. Demographic,
disease, and treatment related variables were retrieved. Multivariate logistic regression analysis
was performed to individually identify risk factors for depression and anxiety.
Results—Our study included a total of 707 CD and 530 UC patients who underwent bowel
resection surgery and did not have depression prior to surgery. The risk of depression 5 years after
surgery was 16% and 11% in CD and UC respectively. We found no difference in the risk of
depression following surgery in CD and UC patients (adjusted OR 1.11, 95%CI 0.84 – 1.47).
Female gender, co-morbidity, immunosuppressant use, perianal disease, stoma surgery, and early
surgery within 3 years of care predicted depression after CD-surgery; only female gender and co-
morbidity predicted depression in UC. Only 12% of the CD cohort had ≥ 4 risk factors for
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depression, but among them nearly 44% were subsequently received a diagnosis code for
depression.
Conclusion—IBD-related surgery or hospitalization is associated with a significant risk for
depression and anxiety with a similar magnitude of risk in both diseases.
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INTRODUCTION
Crohn’s disease (CD) and ulcerative colitis (UC) are chronic inflammatory diseases of the
gastrointestinal tract affecting over 1.4 million Americans and accounting for an estimated
$6 billion in direct healthcare costs1–3. They are associated with considerable indirect costs
in lost productivity and days absent from work. Nearly two-thirds of patients with CD
require at least one surgery during the course of their disease4, 5 and a significant proportion
require hospitalization4. Up to a third of patients with UC may require surgical treatment of
their disease, either for refractoriness to medical therapy or cancer6–8. While recurrence of
disease is common after surgery for CD, colectomy is considered curative for UC though
subsequent ileo-anal pouch related issues including single or recurrent episodes of pouchitis,
or other pouch-related complications occur frequently9.
Psychiatric co-morbidity, in particular depression and anxiety, are common in patients with
inflammatory bowel disease (IBD). Lifetime prevalence of major depression may approach
30% and anxiety may occur even more commonly10–13. While many cross-sectional or
prospective studies have examined the frequency of occurrence of such co-morbidity14–16,
fewer have examined risk factors12. Intuitively, disease severity and activity are important
determinants of psychological effects of underlying bowel disease11, 17–19. Nevertheless, no
prior studies have specifically addressed the frequency of occurrence of or risk factors for
depression or anxiety following an IBD -related surgery or hospitalization which represent
major events in the natural history of disease. Identifying such subgroups may identify a
high-risk cohort of patients who could be targeted for screening for such co-morbidity, and
early interventions to improve outcomes. Furthermore, no studies have specifically
compared the occurrence of such psychiatric co-morbidity following surgery or
hospitalization between CD and UC.
We performed this study with the aims of (1) examining the risk of depression and anxiety
following an IBD-related surgery or hospitalization in a large multi-institution cohort; and
(2) identifying the risk factors for such psychiatric co-morbidity following surgery or
hospitalization in IBD patients; and (3) to compare the occurrence of such psychiatric co-
morbidity in those with CD to UC patients undergoing interventions.
METHODS
Study Cohort
This study included a cohort of patients with CD or UC seen at two large tertiary referral
hospitals (Massachusetts General Hospital, and Brigham and Women’s Hospital) in Boston
serving over 4 million people. Prior work has described the creation of this cohort in
detail20. In brief, we first extracted all patients with ≥ 1 International Classification of
Diseases, 9th edition (ICD-9) code for CD (555) (n = 14,288) or UC (556) (n=14,355).
Subsequently, using an algorithm developed using clinical, laboratory, endoscopy, and
pathology data, refined using ICD-9 codes and free text natural language processing
concepts, we identified a cohort of 5,506 CD and 5,522 UC patients with a positive
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predictive value of 97%, with validation of the algorithm through additional chart review by
a board certified gastroenterologist20.
Variables
Information was obtained on age, age at the time of the first diagnosis code of CD or UC,
gender, and modified Charlson co-morbidity index21 (excluding variables related to anxiety,
depression) using ICD-9 codes. We identified the cohort of patients who underwent a bowel
resection through the use of ICD-9 codes for abdominal surgery (Supplementary Table 1),
and extracted the date of the occurrence of such procedures. Information was also obtained
on disease-related complications including fistulizing or stricturing disease, and perianal
disease for CD patients using ICD-9 codes (Supplementary Table 1). Use of medications
including immunomodulators (azathioprine, 6-mercaptopurine, methotrexate), anti-tumor
necrosis factor α (anti-TNF) therapies (infliximab, adalimumab), and corticosteroids
(prednisone, budesonide) was ascertained as codified data using the electronic prescription
function of our electronic medical record (EMR). IBD-related hospitalizations were
identified as those with a primary diagnosis of CD or UC upon discharge from the hospital.
We also identified patients who had undergone at least one stoma surgery (ICD-9 46.1,
46.2), and those who had undergone more than 1 surgery. To adjust for intensity of
healthcare utilization, we included a variable - ‘number of facts’ - which included total
number of distinct medical encounters including office visits, laboratory tests, radiologic
studies, and inpatient or outpatient procedures. This, divided by duration of follow-up,
yielded ‘fact density’ which was a measure of healthcare utilization per unit time of follow-
up.
Outcomes
Our primary outcome of the study was the development of anxiety and depression defined as
in previous studies using ICD-9 codes for depressive disorders (296.2, 296.3, 298.0, 311) or
generalized anxiety (293.84, 300.0, 313.0)13, 22. To validate the accuracy of the ICD-9 codes
for depression and anxiety we selected a random subset of 100 patients from both hospitals
with each of these codes, reviewed their medical records and found a positive predictive
value for a diagnosis of depression or anxiety to be 92% and 90% respectively. The
predictive value was similar from both major hospitals (MGH and BWH). Patients who had
a diagnosis code for depression or anxiety prior to or on their first date of surgery, or within
30 days after the date of surgery were excluded from this study to reduce likelihood of
identifying prevalent cases (Figure 1). Similarly, in the analysis of hospitalizations, those
with psychiatric co-morbidity (major depression or anxiety) at the time of or prior to an
IBD-related hospitalization, or within 30 days of such a hospitalization were excluded.
Statistical Analysis
All data was analyzed using Stata 11.0 (StataCorp, College Station, TX). Continuous
variables were summarized using means and standard deviations and compared using t-tests.
Categorical variables were expressed as proportions and compared using the chi-square test.
Multivariate logistic regression analysis adjusting for potential confounders formed our
main analysis examining predictors of depression or anxiety following surgery or
hospitalization. Variables were selected for entry into the multivariate model based on
significance at p < 0.1 on univariate analysis. The multivariate analysis was carried out
using the forward stepwise procedure, retaining variables with p < 0.05. To account for
secular trends in coding, year of surgery was included as a separate variable in all our
multivariate models. We examined the occurrence of such psychiatric co-morbidity in the
entire CD/UC cohort as well as each disease subgroup individually, comparing the rates
across CD and UC. The predictors of depression and anxiety were also examined in the
overall cohort as well as CD and UC separately. We performed sensitivity analyses to
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examine if having the diagnosis code for post-surgery depression or anxiety was a reflection
of frequency of healthcare utilization by adjusting for fact density as described above, and
for frequency of outpatient visits. The study was approved by the Institutional Review Board
of Partners Healthcare.
RESULTS
Study Population
There were a total of 744 CD and 556 UC patients in our cohort who underwent ≥ 1 bowel
resection surgery and did not have a diagnosis of depression prior to surgery. Among these,
63 had their first diagnosis code for depression within 30 days of the surgery (median 1 day)
and were excluded resulting in 707 CD and 530 UC patients who were included in the
analysis of post-surgery depression (Figure 1). The mean age of the cohort was 48 years
with a mean age at surgery of 42 years. Just under half the cohort were women (47%). The
cohort for analysis of anxiety following an IBD-related surgery comprised 1,183 patients.
Risk of Depression and Anxiety following IBD-related surgery or hospitalization
A total of 128 CD patients subsequently were given a diagnosis code for depression at a
median of 2.2 years. Among those who required surgery, the risk of depression at 1, 2, and 5
years after surgery was 6, 8, and 16% (Figure 2). Similarly, 54 UC patients were given a
diagnosis of depression at a median of 2.5 years. Interestingly, the risk of depression at 1, 2,
and 5 years after surgery for UC was similar to the CD cohort at 5, 7 and 11% respectively
(Figure 2). The crude overall frequency of depression was higher than we found for those
undergoing surgery for diverticulitis (9%) or inguinal hernia (7%, p < 0.05). On multivariate
logistic regression, adjusting for age, gender, co-morbidity, there was no difference in the
risk of depression among post-surgery CD and UC patients (adjusted odds ratio (OR) 1.11,
95% confidence interval (CI) 0.84 – 1.47) suggesting a similar risk of post-surgery
depression in both diseases. Among the entire CD cohort, 4,762 patients never required
surgery. Compared to such patients, we observed a significantly elevated risk of depression
in patients who required surgery (adjusted OR 1.34, 95% CI 1.01 – 1.77). Compared to UC
patients who never required surgery (n = 4,928), those who did undergo surgery did not
demonstrate this increase in risk for depression following surgery (OR 1.21, 95% CI 0.93 –
1.58).
The risk of anxiety following IBD-related surgery at 1, 2, and 5 years was 7%, 9%, and 14%
in CD patients and 7%, 10% and 12% in UC patients. There was no difference in the
likelihood of anxiety based on IBD type (Odds ratio for CD vs. UC 1.09, 95% CI 0.82 –
1.44). Unlike what we identified for depression, the likelihood of anxiety following an IBD-
related surgery was only mildly elevated compared to those who never underwent surgery
for either CD (OR 1.20, 95% CI 0.93 – 1.55) or UC (OR 1.26, 95% CI 0.96 – 1.65).
A total of 2,062 CD patients and 1,345 UC patients required at least one IBD-related
hospitalization, among who 33% and 41% subsequently required surgery. An IBD-related
hospitalization itself was associated with a significant risk of depression. Even excluding
those who subsequently underwent surgery, the risk of depression 5 years after a CD-related
hospitalization was 17% with a corresponding risk of anxiety of 12%. This was nearly two-
fold the risk of depression in those who never required hospitalization (OR 1.91, 95% CI
1.60 – 2.77). Similarly for UC, a disease related hospitalization was associated with an
increase in risk for depression (OR 1.28, 95% CI 1.06 – 1.54) and anxiety (OR 1.32, 95% CI
1.09 – 1.59) compared to those who were never hospitalized.
Ananthakrishnan et al. Page 4
Am J Gastroenterol. Author manuscript; available in PMC 2014 April 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Predictors of Depression and Anxiety following IBD-related surgery
Table 1 presents the characteristics of the patients, stratified by disease type and depression
status. Both UC and CD patients who developed depression following surgery were more
likely to be female and have greater co-morbidity. However, there were also differences
between the two diseases. In CD, depressed patients were also more likely to be younger
than 35 years at the time of surgery, or had surgery within 3 years of first diagnosis code for
CD. The only disease phenotype associated with depression was the presence of perianal
disease which was nearly twice as common in those with depression as those without. Those
who developed depression were significant more likely to have required a stoma than those
without (27% vs. 15%). The risk of depression 5 years after stoma surgery was 31%
compared to 19% in those who never underwent stoma surgery (Figure 3). In UC, early
surgery within 3 years was associated with an increased risk for depression similar to that
seen for CD. However, there was no difference by age at surgery. Interestingly, there was
also difference in risk of depression by requirement of a stoma in UC patients, likely due to
the high frequency of requiring a stoma (temporary or permanent) as part of a two- or three-
stage total colectomy with ileo-anal pouch reconstruction.
Since there were differences in risk factors, we performed separate stepwise multivariate
logistic regression analyses for both diseases. In CD, the strongest predictor was non-IBD
medical co-morbidity (Table 2). Having a stoma was the next strongest predictor with an OR
of 1.90 (95% CI 1.15 – 3.13). Female gender, perianal disease, need for immunomodulator
therapy, and early surgery within 3 years also moderately increased risk of depression
following surgery. The risk of depression increased with the number of risk factors; only 8%
of those with 0 or 1 risk factor subsequently developed depression compared to 20% of
those with 2 or 3 risk factors, and 44% of those with 4 or more risk factors (Figure 4).
However, the distribution of risk factors was also not uniform between the risk strata; only
2% of those in the lowest risk category had a stoma surgery compared to 46% of the highest
risk stratum. On the other hand, for UC, only female gender (OR 2.92) and Charlson score ≥
3 (OR 3.73) were associated with increased risk of depression (Table 2). Multivariate
analysis for predictors of anxiety revealed a significant overlap with the risk factors for
depression with similar effect sizes for nearly all parameters for both CD and UC (Table 3).
Sensitivity Analysis
We performed a variety of sensitivity analysis to examine the robustness of our findings.
Primarily, to determine if the increased risk of anxiety or depression following surgery was
solely a reflection of increased healthcare utilization (and consequently, increase in the
number of diagnosis codes) in such patients, we adjusted for the number of outpatient
gastroenterology office visit, all outpatient visits with a diagnosis of CD or UC, and number
of inpatient hospitalizations, and found no attenuation of our effect sizes. Similarly, our OR
estimates were rendered larger adjusting for density of healthcare utilization.
DISCUSSION
There is an increased risk of depression and anxiety in patients with CD or UC10–13. The
extent to which this increased risk is determined by severity of disease is unclear.
Furthermore, there have been no prior studies that have quantified the risk of such
psychiatric co-morbidity after IBD-related surgery or hospitalization which represent major
events in the natural history of IBD. Using a multi-institutional cohort, we demonstrate that
even after excluding those who received a diagnosis of depression prior to surgery, CD and
UC patients who underwent an IBD-related surgery had a 16% and 11% risk of receiving a
diagnosis of depression at 5 years, with a similar substantial risk of anxiety. Furthermore,
despite surgery for UC being considered curative, we observed a similar risk between both
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diseases. We also identified several sub-groups of patients at higher risk of such co-
morbidity, which may facilitate targeted screening and early intervention.
Several studies have examined the co-occurrence of psychiatric co-morbidity in patients
with IBD13–16, 23. However, there is limited literature examining risk factors for
psychological distress in patients with IBD. Nahon et al. administered a questionnaire to
1,663 patients with IBD and identified 11% of patients to be depressed and 41% to be
anxious12. On multivariate analysis, severity of disease defined as requiring two or more
courses of steroids, hospitalization, need for immunosuppressive therapy or intestinal
resection was an independent risk factor for anxiety but not depression. However, this broad
definition of severe disease resulted in nearly 90% of their cohort irrespective of psychiatric
co-morbidity being classified as having severe disease, limiting the utility of such composite
definitions. Indeed when restricting their analysis to individual components of disease
severity, they found that past history of surgery was associated with a lower risk of anxiety
and had no effect on risk of depression. Our study differs from the prior studies in that we
specifically focused on a relatively homogenous cohort of CD or UC patients who had all
undergone surgery or required hospitalization. By specifically excluding those who received
a diagnosis of depression or anxiety prior to surgery, we attempted to minimize the number
of prevalent cases as well as the possibility of reverse causation or confounding where
disease activity predicts both surgery as well as occurrence of psychiatric co-morbidity.
A key and interesting finding from our study is that the risk of depression or anxiety
following IBD-related surgery or hospitalization was similar in CD and UC. While surgery
for CD is usually not curative, is followed by nearly universal disease recurrence with only
mild attenuation of this risk with existing medical therapies, a total colectomy for UC is
considered curative. There are a few possible reasons for persistence of the risk for
depression and anxiety in UC patients following surgery similar to that for CD. First, even
after an ileal-pouch, patients can continue to be have frequency of bowel movements
including need for nocturnal bowel movements which could affect health-related quality of
life, which could in-turn lead to depressive symptoms24. Secondly, up to half of the patients
may have at least one episode of pouchitis while one-quarter may have recurrent episodes9.
Such fluctuations in disease activity could also influence risk of depression or anxiety. This
is consistent with the findings from a small study by Hauser et al. that patients with an IPAA
did not differ in their risk of depression compare to UC patients without IPAA but were
more likely to be depressed than the general population25. Other studies have similarly
shown that patients with an IPAA continue to have impairment in quality of life compared to
the general population26, 27 though the literature in this area has yielded conflicting
results28.
We also identified common and distinct risk factors for depression following-IBD related
surgery. Female gender was common across both diseases, consistent with prior studies
examining health-related quality of life and psychiatric co-morbidity in IBD29–32. In a
prospective study, Beaugerie et al. demonstrated that perianal disease was associated with a
disabling course of CD33. A high proportion of patients with perianal CD have depressive
symptoms34, and demonstrate long-term impairment of quality of life35. In addition, early
surgery defined as undergoing a resection within 3 years of first CD diagnosis code in our
health system also increased risk of depression post-operatively, consistent with the
hypothesis associating aggressive disease behavior with psychological co-morbidity.,
Requiring an ostomy bag is one of the highest rated concerns among CD and UC
patients36–38. In the present study, among CD patients, the risk of depression or anxiety was
influenced quite strongly by having an ostomy which was the strongest risk factor after non-
IBD co-morbidity. However, we found no such effect on UC patients which could be due to
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the high frequency of stoma procedures (as part of two- or three-stage colectomy surgeries
in UC). The literature on the effect of stoma on risk of subsequent psychological co-
morbidity has been inconsistent. After surgery for colorectal cancer, having a stoma is
associated with worse body image39 and increases risk for anxiety or depression. However,
in CD, where surgery may not represent a permanent cure from disease, and patients may
continue to experience symptoms related to ongoing bowel or perianal disease, having a
stoma has not been consistently associated with worse quality of life when compared to
other CD controls35, 40. However, no prior studies have specifically examined the effect of
stoma or multiple surgeries on post-operative anxiety or depression in an IBD cohort. In
addition, the association with non-IBD co-morbidity suggests that such patients may be
more susceptible to functional impairment and consequences of IBD-related surgery or
hospitalization. The association between co-morbidity and increased healthcare utilization
post-operatively has also been demonstrated in other cohorts41, 42, suggesting management
of IBD patients with such co-morbidity, particularly in the setting of severe disease
requiring surgery remains challenging.
Finally, another important finding from out study was that an IBD-related hospitalization
even in the absence of subsequent surgery was associated with a significant risk for
depression and anxiety. This demonstrates that in addition to their effect on healthcare costs,
hospitalizations remain an important event in disease course of both CD and UC. As
demonstrated by prior studies, those requiring hospitalization form a high risk cohort for
subsequent surgery4, 43, 44, but even in the absence of such an eventuality, remain at risk for
psychological co-morbidity associated with their disease. Consideration must be given for
routine screening for depression and anxiety in this cohort as well.
Our study has several implications. To our knowledge, ours is the first study specifically
examining the overall occurrence of depression and anxiety following IBD-related surgery
or hospitalization, as well the comparative incidence between both diseases. Our
examination of predictors of depression or anxiety suggest that there are strong
demographic, disease, or surgery related characteristics that place a patient at a substantially
elevated risk of psychological co-morbidity even among a cohort with relative homogeneity
in their disease severity. We suggest the need to routinely screen such patients for
depression and anxiety as part of standard care in the immediate and late post-operative
period, as well as after an IBD-related hospitalization. Given the significant morbidity and
healthcare utilization associated with psychiatric co-morbidity, there is need for continued
research into effective interventions to identify and treat such patients, and whether
preventive interventions may be warranted in high-risk patients.
There are a few limitations to our study. First, we relied on administrative coding to identify
the presence and date of diagnosis of depression or anxiety in the postoperative setting as
well as predictors which may result in misclassification. However, misclassification is
unlikely to be differential between the various risk factors, and we performed a validation of
the ICD-9 codes used. Recognizing the increased risk for depression and anxiety, future
prospective studies are necessary with structured evaluation of mood and other psychiatric
co-morbidity following IBD-related surgery or hospitalization. Second, we did not have
accurate and comprehensive information on the use of antidepressant or anti-anxiety
medications in our cohort. Third, owing to the referral nature of our institutions, further
studies examining our hypothesis in a population based cohort will help confirm the
generalizability of our results. Given the linear increase in depression and anxiety diagnosis
over time, it is unlikely that our findings are solely due to increased frequency of healthcare
utilization and thus, the number of diagnosis codes, in the immediate perioperative period.
We also did not have information on smoking status which could influence risk of surgery in
CD.
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In conclusion, we demonstrate that IBD-related surgery or hospitalization is associated with
a significant risk for depression and anxiety in both CD and UC with similar magnitudes of
risk across both diseases. Female gender and non-IBD co-morbidity were common risk
factors for depression or anxiety in both CD and UC. Requirement for a stoma was a strong
risk factor for depression following surgery in CD-but not UC patients. Continued screening
for psychiatric co-morbidity following IBD-related surgery or hospitalization should be part
of comprehensive IBD care, particularly for high-risk patients. There is need for ongoing
research into effective modalities to improve health-related quality of life and other
outcomes in such patients.
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What is known?
• Anxiety and depression are common in patients with Crohn’s disease and
ulcerative colitis
• Severity of disease may be associated with risk of psychiatric co-morbidity
• The incidence of depression or anxiety after an IBD-related surgery or
hospitalization, or the risk factors for such psychiatric co-morbidity is unknown.
What is new here?
• Approximately 16% of CD patients and 11% of UC patients develop depression
at 5 years after undergoing IBD-related surgery with a similar risk between CD
and UC.
• Female gender, younger age at surgery, undergoing surgery soon after a
diagnosis of CD, or requirement for a stoma were associated with increased risk
of depression in CD while only female gender and co-morbidity predicted
depression in UC.
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Figure 1.
Flowchart demonstrating development of Crohn’s disease and ulcerative colitis cohorts
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Figure 2.
Risk of depression following IBD-related surgery in Crohn’s disease and ulcerative colitis
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Figure 3.
Risk of depression following surgery in Crohn’s disease, stratified by requirement for a
stoma
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Figure 4. Frequency of depression following surgery in Crohn’s disease, stratified by the number
of risk factors
(a) Distribution of risk factors for depression following CD-related surgery
(b) Frequency of depression stratified by presence of risk factors
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Table 2
Multivariate analysis of risk factors for depression following surgery in Crohn’s disease and ulcerative colitis
Crohn’s disease
Characteristic Adjusted Odds Ratio 95% confidence interval
Female gender 1.77 1.16 – 2.71
Charlson score ≥ 3 4.31 2.82 – 6.57
Surgery within 3 years 1.54 1.01 – 2.37
Immunomodulator use 1.56 1.03 – 2.38
Stoma surgery 1.90 1.15 – 3.13
Perianal disease 1.64 1.01 – 2.69
Ulcerative colitis
Female gender 2.92 1.80 – 4.76
Charlson score ≥ 3 3.73 2.33 – 5.97
All risk factors retained in the multivariate analysis by stepwise regression are described in the table.
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Table 3
Multivariate analysis of risk factors for anxiety following surgery in Crohn’s disease and ulcerative colitis
Crohn’s disease
Characteristic Adjusted Odds Ratio 95% confidence interval
Female gender 2.07 1.35 – 3.19
Charlson score ≥ 3 1.84 1.19 – 2.84
Surgery within 3 years 2.19 1.44 – 3.33
Stoma surgery 1.73 1.05 – 2.85
≥ 2 surgeries 1.79 1.09 – 2.93
Ulcerative colitis
Age (per 1 year) 0.98 0.97 – 1.00
Female gender 1.84 1.18 – 2.87
Charlson score ≥ 3 3.26 1.98 – 5.38
All risk factors retained in the multivariate analysis by stepwise regression are described in the table.
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